Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Depression treatments including physical activity and sleep management has been shown to relieve depressive symptoms among participants suffering depressive episodes. This study evaluates the potential of these methods as prevention of depressive relapse or recurrence
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Therapist-assisted iCBT | Experimental | Internet-delivered cognitive behavioral therapy (iCBT), containing physical activity and sleep management for preventing depressive relapse. Monthly depression screening with therapist feedback. |
|
| Monthly screening with feedback | Active Comparator | Monthly depression screening with therapist feedback. |
|
| Control | No Intervention | No intervention, follow-up along with all participants at 6 and 12-months. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Therapist-assisted iCBT | Behavioral | 13 week long individualized prevention program containing, physical activation, sleep management, tailored cognitive behavioral therapy for individual problems. |
| Measure | Description | Time Frame |
|---|---|---|
| Depressive relapse (change in diagnostic status, SCID-I) | Monthly screening via Montgomery-Asberg Depression Rating Scale - Self rated & Structured Clinical Interview for DSM IV | Baseline - 12 months |
| Change from baseline in depressive symptoms (MADRS-S) | Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated. | Baseline - 6 months |
| Change from baseline in depressive symptoms (MADRS-S) | Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated. | Baseline - 12 months |
| Change from baseline in depressive symptoms (MADRS-S) | Change in depressive symptoms will be measured by an internetbased version of the Montgomery-Asberg Depression Rating Scale - Self rated. | Monthly, 0-12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in health related quality of life (EQ-5D) | Health related quality of life will be measured by an internet based version of the EQ-5D. | Baseline - 3 months |
| Change from baseline in health related quality of life (EQ-5D) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lars-Gunnar Lundh, Professor | Lund University, Departement of psychology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vuxenpsykiatrimottagning allmänpsykiatri Fosievägen Malmö | Malmö | Skåne County | 21431 | Sweden |
Not provided
| ID | Term |
|---|---|
| D003863 | Depression |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Monthly screening with feedback | Behavioral | Participants are screened with a depression inventory each month and receives feedback from a therapist on the results |
|
Health related quality of life will be measured by an internet based version of the EQ-5D.
| Baseline - 6 months |
| Change from baseline in health related quality of life (EQ-5D) | Health related quality of life will be measured by an internet based version of the EQ-5D. | Baseline - 9 months |
| Change from baseline in health related quality of life (EQ-5D) | Health related quality of life will be measured by an internet based version of the EQ-5D. | Baseline - 12 months |
| Change from baseline in Outcomes Questionnaire 45 (OQ-45) | The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time. | Baseline - 3 months |
| Change from baseline in Outcomes Questionnaire 45 (OQ-45) | The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time. | Baseline - 6 months |
| Change from baseline in Outcomes Questionnaire 45 (OQ-45) | The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time. | Baseline - 9 months |
| Change from baseline in Outcomes Questionnaire 45 (OQ-45) | The OQ-45 measures functioning in 3 domains: Symptom distress (heavily loaded for depression and anxiety), Interpersonal functioning, and Social Role. It enables the clinician to assess functional level and change over time. | Baseline - 12 months |
| Change from baseline in the International Physical Activity Questionnaire (IPAQ) | The International Physical Activity Questionnaire is a measure of physical activity | Baseline - 3 months |
| Change from baseline in the International Physical Activity Questionnaire (IPAQ) | The International Physical Activity Questionnaire is a measure of physical activity | Baseline - 6 months |
| Change from baseline in the International Physical Activity Questionnaire (IPAQ) | The International Physical Activity Questionnaire is a measure of physical activity | Baseline - 9 months |
| Change from baseline in the International Physical Activity Questionnaire (IPAQ) | The International Physical Activity Questionnaire is a measure of physical activity | Baseline - 12 months |
| Morisky Medication Adherence Scale (MMAS-8) | Self-reported measure of medication adherence | Baseline - 3 months |
| Morisky Medication Adherence Scale (MMAS-8) | Self-reported measure of medication adherence | Baseline - 6 months |
| Morisky Medication Adherence Scale (MMAS-8) | Self-reported measure of medication adherence | Baseline - 9 months |
| Morisky Medication Adherence Scale (MMAS-8) | Self-reported measure of medication adherence | Baseline - 12 months |
| Insomnia Severity Index (ISI) | Insomnia issues | Baseline - 3 months |
| Insomnia Severity Index (ISI) | Insomnia issues | Baseline - 6 months |
| Insomnia Severity Index (ISI) | Insomnia issues | Baseline - 9 months |
| Insomnia Severity Index (ISI) | Insomnia issues | Baseline - 12 months |
| Alcohol Use Disorder Identification Test (AUDIT) | Baseline - 3 months |
| Alcohol Use Disorder Identification Test (AUDIT) | Baseline - 6 months |
| Alcohol Use Disorder Identification Test (AUDIT) | Baseline - 9 months |
| Alcohol Use Disorder Identification Test (AUDIT) | Baseline - 12 months |
| Time to depressive relapse | Time to depressive relapse is recorded as secondary outcome variable | Baseline - 12 months |
| Self reported treatment seeking | Treatment seeking among participants is recorded as secondary outcome variable | Baseline - 12 months |